Not Signed In - Watson Pharmaceuticals Receives FDA Approval For Levonorgestrel And Ethinyl Estradiol Tablets USP, 0.1mg / 0.02mg
Fri, 02 Jun 2006 06:00 AM EST
... WatsonPharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceuticalcompany, announced today that it has received final approval from theUnited States (U.S.) Food and Drug Administration (FDA) on its AbbreviatedNew Drug Application for levonorgestrel and ethinyl estradiol tablets USP,0.1mg / 0. [click link for full article] ...
Related Topics
- Estradiol and Levonorgestrel
- Estradiol
- Ethinyl Estradiol and Levonorgestrel Emergency Contraception
- Ethinyl Estradiol
- Estradiol and Norgestimate
- Drospirenone and Ethinyl Estradiol
- Ethinyl Estradiol and Norelgestromin Transdermal System
- Estradiol Vaginal Tablets
- Ethinyl Estradiol and Norethindrone Acetate (Hormone Replacement Therapy)
- Carbinoxamine and Pseudoephedrine Tablets
- Ethinyl Estradiol and Desogestrel
- Ethinyl Estradiol and Norgestrel
- Norgestrel
- Etonogestrel and ethinyl estradiol vaginal ring
- Ethinyl Estradiol and Levonorgestrel
- Ethinyl Estradiol and Norgestimate
- Vaccine Testing & Approval
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Estradiol Injection
email this page
print this page
bookmark this page
feedback on this page
